Introducing exsig™

Home | Investors | RNS | Introducing exsig™

 

 

We are proud to have launched exsig™ a family of extraction workflow products tailored to suit your requirements in testing.  exsig™ is a product range like no other consisting of various products from complete workflow solutions to enhanced magnetic bead technology, so if one product doesn’t suit your needs another will. Together exsig™ can bring to your lab a solution that works on getting the most out of your sample from start to finish to give you great quality and trustworthy results.


exsig™ COVID-19 Direct

exsig™ COVID-19 Direct is a total workflow solution with all reagents and components provided from beginning to end.  In using exsig™ COVID-19 Direct it reduces your handling steps minimising any chances for error. With total chemistry optimisation, you can have complete confidence your results will be of great quality.  exsig™ COVID-19 Direct includes our globally renowned clinical diagnostic genesig® Real-Time PCR Coronavirus COVID-19 (CE IVD) and can be used with swab types including PBS, saline and dry swabs.

Viral inactivation; Preparation, Amplification, Diagnosis

“This product offers a simplified workflow that reduces sample processing time and offers laboratories the ability to vastly increase their screening for SARS-CoV-2”  

Dr. Paul Oladimeji, Head of Product Development

exsig™ Mag

exsig™ Mag  facilitates a high-quality ultra-sensitive nucleic acid purification for high-throughput extractions. Providing flexibility in magnetic-bead extraction chemistry for a variety of samples type and provides users with 5,000 extractions.  exsig™ Mag is fully automatable and has the compatibility to be widely used with liquid handlers and extraction robots.

exsig™ Mag compliments the genesig® Real-Time PCR COVID-19 (CE) for peace of mind in offering the most accurate diagnosis possible.

“exsig™ Mag is an ultra-sensitive extraction solution, providing the user with total confidence in their results across a wide spectrum of applications, as demonstrated by the high sensitivity when used in conjunction with the genesig® COVID-19 CE IVD qPCR assay”  

Adam Herridge, Product Manager

If you would like to find out more about our exsig™ range please contact us.

 

Download as a PDF
Return to RNS Feed